Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation
DERM EV TOPIC
1 other identifier
observational
55
0 countries
N/A
Brief Summary
Check the safety under normal conditions of use through the verification of emergence signs of irritability and sensitisation of the genital mucosa.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2016
CompletedStudy Start
First participant enrolled
January 1, 2017
CompletedFirst Posted
Study publicly available on registry
January 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedJanuary 2, 2017
December 1, 2016
1 month
December 29, 2016
December 29, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of adverse effects in maximized conditions
60 days
Eligibility Criteria
Patients with age from 18 to 70 years old, with skin color varying between clear caucasian to dark.
You may qualify if:
- Age between 18 to 70 years old;
- Skin types: I (light caucasian), II (caucasian), III (light dark) and IV (dark)
- intact skin where the product will be applied
- Agreement to comply with the test procedures and attend the clinic in the days and ixed times for medical assessments and application and reading of dressings
- Signature of informed consent form
You may not qualify if:
- Pregnancy and lactation
- Use of anti-inflammatory and immunosuppressive drugs from 30 days up to three months prior to selection;
- Diseases that cause immune suppression;
- Personal history of atopy;
- History of sensitisation and irritability to topical products;
- Active cutaneous pathologies (local and / or scattered) that may interfere in the study results;
- Use of new drugs and/or cosmetics during the experiment;
- Skin reactivity;
- Previous participation in a study with the same product under test;
- Volunteers who have congenital or acquired known immunodeficiency;
- Relevant medical history or current evidence of alcohol or other drugs abuse;
- Known historical or suspected intolerance to any ingredient of the product under study (product under test or comparator);
- Sponsor's employees involved in the study, or close family member of an employee involved in the study;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kley Hertz S/Alead
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 29, 2016
First Posted
January 2, 2017
Study Start
January 1, 2017
Primary Completion
February 1, 2017
Last Updated
January 2, 2017
Record last verified: 2016-12